STOCK TITAN

Khrom group reports 5.66% stake in Acadia Healthcare (NASDAQ: ACHC)

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Acadia Healthcare investor group led by Khrom Investments reports beneficial ownership of 5,201,533 shares, representing 5.66% of outstanding common stock as of March 31, 2026. The filing states Khrom Investments directly holds 5,194,625 shares and Eric Khrom directly holds 6,928 shares.

The disclosure explains voting and dispositive power: Khrom Capital exercises shared voting and dispositive power over the shares held by Khrom Investments, and Mr. Khrom may be deemed to share those powers through affiliated entities; Mr. Khrom disclaims beneficial ownership except to the extent of any pecuniary interest.

Positive

  • None.

Negative

  • None.

Insights

Khrom group discloses a >5% stake with affiliated voting arrangements.

The filing documents an aggregate position of 5,201,533 shares (approximately 5.66%) as of March 31, 2026, with 5,194,625 shares held directly by Khrom Investments. The text attributes shared voting and dispositive power to Khrom Capital regarding those shares.

This structure is typical for investment-manager relationships; subsequent filings could clarify any changes in ownership percentages or voting arrangements when transactions occur.

Disclosure meets Section 13 requirements and signals a passive ownership report.

The Schedule 13G/A amendment reports beneficial ownership and includes the issuer's outstanding share count reference from the issuer's Form 10-Q. It clarifies direct holdings, shared powers, and a disclaimer by Mr. Khrom.

Material investor implications depend on future transactions; this amendment itself is informational and does not state plans to buy or sell.

Aggregate beneficial ownership 5,201,533 shares As of March 31, 2026
Percent of class 5.66% Based on 91,967,027 outstanding shares (issuer Form 10-Q)
Khrom Investments direct holdings 5,194,625 shares Direct beneficial owner per filing
Eric Khrom direct holdings 6,928 shares Direct beneficial owner per filing
beneficially own regulatory
"As of March 31, 2026, the Reporting Persons may be deemed to beneficially own in the aggregate 5,201,533 Shares."
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
sole voting power / shared voting power regulatory
"Sole Voting Power 5,194,625.00 6 | Shared Voting Power 0.00"
Schedule 13G/A regulatory
"This is being filed on behalf of each of the following persons (collectively, the "Reporting Persons")"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Khrom report in Acadia Healthcare (ACHC)?

The Khrom group reports beneficial ownership of 5,201,533 shares, equal to 5.66% of outstanding shares. The figure is stated as of March 31, 2026 and is based on the issuer's outstanding share count in its Form 10-Q.

How many shares does Khrom Investments directly hold in ACHC?

Khrom Investments directly holds 5,194,625 shares. The Schedule 13G/A lists this as the direct beneficial ownership held by Khrom Investments in the issuer.

What role does Khrom Capital have over the reported shares?

Khrom Capital has shared voting and dispositive power over the shares directly owned by Khrom Investments, as stated in the filing, reflecting its management role over those accounts.

Does Eric Khrom personally claim ownership of all reported shares?

Eric Khrom is reported as owning 6,928 shares directly and may be deemed to share power over Khrom Investments' holdings through affiliated entities; he expressly disclaims beneficial ownership except for any pecuniary interest.

What share count did Acadia report for outstanding shares used in the percentage?

The filing uses 91,967,027 outstanding shares as reported in the issuer's Form 10-Q, which the Schedule 13G/A cites to calculate the 5.66% ownership percentage.





00404A109

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Khrom Investments Fund, LP
Signature:Eduard Skutelsky
Name/Title:Eduard Skutelsky | Chief Operating Officer
Date:05/15/2026
Khrom Capital Management LLC
Signature:Eduard Skutelsky
Name/Title:Eduard Skutelsky | Chief Operating Officer
Date:05/15/2026
Eric Khrom
Signature:Eric Khrom
Name/Title:Eric Khrom
Date:05/15/2026